DR. LUCAS HELLER M.D.
Prescription History 1982970976
Internal Medicine - Endocrinology, Diabetes & Metabolism in Irwin, PA

Active since March 24, 2012PECOS EnrolledAccepts Medicare Assignment
8775 NORWIN AVE STE 100, IRWIN, PA 15642(833) 604-7211(724) 537-1066 Get Directions

NPPES record last updated: September 10, 2025. Verified against the NPPES registry weekly; last sync: August 16, 2026.

Record update history: Sep 10, 2025, Apr 9, 2019 (2 updates tracked since 2019).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. LUCAS HELLER M.D., an active Endocrinology, Diabetes & Metabolism specialist practicing in Irwin, PA. Our medical registry currently tracks 63 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 3,412 documented patient claims. Among these therapy options, the most frequently utilized medication is Levothyroxine Sodium, which accounts for 467 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

63
Medications
3,412
Total Claims
7,654
30-Day Fills
Levothyroxine Sodium
Most Prescribed · 467 claims
View details
63 medications · 2023 Medicare Part D
Medicare Part D medications prescribed by DR. LUCAS HELLER M.D. in 2023, with prescription volumes, average cost per fill, and PA state comparisons
Medication Prescriptions (2023)Rx (2023) Avg Cost per FillCost / Fill Vs. Other PA PrescribersVs. PA Avg

About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾

It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

In 2023, this provider wrote 467 Medicare prescriptions for Levothyroxine Sodium, about 2.7 times the volume of the typical Pennsylvania prescriber of this medication (171). Medicare paid an average of $21.50 per fill, versus $16.47 statewide.

How often this provider prescribes it

This provider
467
PA average
171.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$21.50
PA average
$16.47

Gross Part D cost per fill; not the patient's out-of-pocket price.

1,286.1
30-Day Fills
standardized to 30-day supplies
38,514
Days of Medication
total across all patients in 2023

About Ozempic: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment.

In 2023, this provider wrote 260 Medicare prescriptions for Ozempic, about 5.9 times the volume of the typical Pennsylvania prescriber of this medication (44). Medicare paid an average of $1,819.73 per fill, versus $1,290.38 statewide.

How often this provider prescribes it

This provider
260
PA average
44.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,819.73
PA average
$1,290.38

Gross Part D cost per fill; not the patient's out-of-pocket price.

484.5
30-Day Fills
standardized to 30-day supplies
14,327
Days of Medication
total across all patients in 2023

About Jardiance: Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Empagliflozin works by increasing the removal of sodium by your kidneys.

In 2023, this provider wrote 227 Medicare prescriptions for Jardiance, about 4.7 times the volume of the typical Pennsylvania prescriber of this medication (48). Medicare paid an average of $1,108.07 per fill, versus $939.26 statewide.

How often this provider prescribes it

This provider
227
PA average
48.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,108.07
PA average
$939.26

Gross Part D cost per fill; not the patient's out-of-pocket price.

426
30-Day Fills
standardized to 30-day supplies
12,752
Days of Medication
total across all patients in 2023

About Trulicity: Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment.

In 2023, this provider wrote 191 Medicare prescriptions for Trulicity, about 4 times the volume of the typical Pennsylvania prescriber of this medication (48). Medicare paid an average of $1,529.09 per fill, versus $1,235.23 statewide.

How often this provider prescribes it

This provider
191
PA average
48.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,529.09
PA average
$1,235.23

Gross Part D cost per fill; not the patient's out-of-pocket price.

297
30-Day Fills
standardized to 30-day supplies
8,650
Days of Medication
total across all patients in 2023

About Metformin Hcl: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾

It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

In 2023, this provider wrote 147 Medicare prescriptions for Metformin Hcl, about 1.4 times the volume of the typical Pennsylvania prescriber of this medication (106). Medicare paid an average of $9.98 per fill, versus $9.38 statewide.

How often this provider prescribes it

This provider
147
PA average
106.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$9.98
PA average
$9.38

Gross Part D cost per fill; not the patient's out-of-pocket price.

390.5
30-Day Fills
standardized to 30-day supplies
11,703
Days of Medication
total across all patients in 2023

About Metformin Hcl Er: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾

It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

In 2023, this provider wrote 142 Medicare prescriptions for Metformin Hcl Er, about 2.7 times the volume of the typical Pennsylvania prescriber of this medication (52). Medicare paid an average of $22.25 per fill, versus $13.63 statewide.

How often this provider prescribes it

This provider
142
PA average
52.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$22.25
PA average
$13.63

Gross Part D cost per fill; not the patient's out-of-pocket price.

340
30-Day Fills
standardized to 30-day supplies
10,184
Days of Medication
total across all patients in 2023

About Toujeo Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

In 2023, this provider wrote 124 Medicare prescriptions for Toujeo Solostar, about 5.2 times the volume of the typical Pennsylvania prescriber of this medication (24). Medicare paid an average of $727.99 per fill, versus $699.22 statewide.

How often this provider prescribes it

This provider
124
PA average
24.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$727.99
PA average
$699.22

Gross Part D cost per fill; not the patient's out-of-pocket price.

244.2
30-Day Fills
standardized to 30-day supplies
7,205
Days of Medication
total across all patients in 2023

About Lantus Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

In 2023, this provider wrote 121 Medicare prescriptions for Lantus Solostar, about 3 times the volume of the typical Pennsylvania prescriber of this medication (41). Medicare paid an average of $691.37 per fill, versus $552.83 statewide.

How often this provider prescribes it

This provider
121
PA average
41.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$691.37
PA average
$552.83

Gross Part D cost per fill; not the patient's out-of-pocket price.

317.4
30-Day Fills
standardized to 30-day supplies
9,447
Days of Medication
total across all patients in 2023

About Synthroid: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾

It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

In 2023, this provider wrote 116 Medicare prescriptions for Synthroid, about 2.6 times the volume of the typical Pennsylvania prescriber of this medication (44). Medicare paid an average of $82.54 per fill, versus $70.80 statewide.

How often this provider prescribes it

This provider
116
PA average
44.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$82.54
PA average
$70.80

Gross Part D cost per fill; not the patient's out-of-pocket price.

325.7
30-Day Fills
standardized to 30-day supplies
9,734
Days of Medication
total across all patients in 2023

About Glimepiride: Glimepiride is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glimepiride belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. Alkaloids derived from TYRAMINE combined with 3,4-dihydroxybenzaldehyde via a norbelladine pathway, including GALANTAMINE, lycorine and crinine. They are found in the AMARYLLIDACEAE plant family.

In 2023, this provider wrote 111 Medicare prescriptions for Glimepiride, about 2.5 times the volume of the typical Pennsylvania prescriber of this medication (44). Medicare paid an average of $24.66 per fill, versus $15.24 statewide.

How often this provider prescribes it

This provider
111
PA average
44.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$24.66
PA average
$15.24

Gross Part D cost per fill; not the patient's out-of-pocket price.

303.3
30-Day Fills
standardized to 30-day supplies
9,099
Days of Medication
total across all patients in 2023

In 2023, this provider wrote 86 Medicare prescriptions for Nano 2nd Gen Pen Needle, about 3 times the volume of the typical Pennsylvania prescriber of this medication (29). Medicare paid an average of $109.75 per fill, versus $93.10 statewide.

How often this provider prescribes it

This provider
86
PA average
29.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$109.75
PA average
$93.10

Gross Part D cost per fill; not the patient's out-of-pocket price.

202.5
30-Day Fills
standardized to 30-day supplies
6,015
Days of Medication
total across all patients in 2023

About Tresiba Flextouch U-100: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.

In 2023, this provider wrote 80 Medicare prescriptions for Tresiba Flextouch U-100, about 2.9 times the volume of the typical Pennsylvania prescriber of this medication (28). Medicare paid an average of $760.79 per fill, versus $700.28 statewide.

How often this provider prescribes it

This provider
80
PA average
28.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$760.79
PA average
$700.28

Gross Part D cost per fill; not the patient's out-of-pocket price.

174.3
30-Day Fills
standardized to 30-day supplies
5,183
Days of Medication
total across all patients in 2023

About Rosuvastatin Calcium: Rosuvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. Show more ▾

It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks. In addition to eating a proper diet (such as a low cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Talk with your doctor for more details. A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES.

In 2023, this provider wrote 76 Medicare prescriptions for Rosuvastatin Calcium, about 79% of the volume of the typical Pennsylvania prescriber of this medication (96). Medicare paid an average of $32.98 per fill, versus $30.45 statewide.

How often this provider prescribes it

This provider
76
PA average
96.0

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$32.98
PA average
$30.45

Gross Part D cost per fill; not the patient's out-of-pocket price.

207.8
30-Day Fills
standardized to 30-day supplies
6,234
Days of Medication
total across all patients in 2023

About Methimazole: Methimazole is used to treat overactive thyroid (hyperthyroidism). Show more ▾

It works by stopping the thyroid gland from making too much thyroid hormone. A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme.

In 2023, this provider wrote 70 Medicare prescriptions for Methimazole, about 2.1 times the volume of the typical Pennsylvania prescriber of this medication (33). Medicare paid an average of $15.16 per fill, versus $12.03 statewide.

How often this provider prescribes it

This provider
70
PA average
33.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$15.16
PA average
$12.03

Gross Part D cost per fill; not the patient's out-of-pocket price.

182.2
30-Day Fills
standardized to 30-day supplies
5,464
Days of Medication
total across all patients in 2023

About Alendronate Sodium: Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Show more ▾

Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.

In 2023, this provider wrote 63 Medicare prescriptions for Alendronate Sodium, about 1.4 times the volume of the typical Pennsylvania prescriber of this medication (44). Medicare paid an average of $8.00 per fill, versus $11.30 statewide.

How often this provider prescribes it

This provider
63
PA average
44.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$8.00
PA average
$11.30

This provider's average cost per fill is below the PA average for this medication.

126.2
30-Day Fills
standardized to 30-day supplies
3,731
Days of Medication
total across all patients in 2023

About Humalog Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

In 2023, this provider wrote 58 Medicare prescriptions for Humalog Kwikpen U-100, about 1.9 times the volume of the typical Pennsylvania prescriber of this medication (31). Medicare paid an average of $981.91 per fill, versus $843.87 statewide.

How often this provider prescribes it

This provider
58
PA average
31.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$981.91
PA average
$843.87

Gross Part D cost per fill; not the patient's out-of-pocket price.

121.5
30-Day Fills
standardized to 30-day supplies
3,641
Days of Medication
total across all patients in 2023

About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾

It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

In 2023, this provider wrote 53 Medicare prescriptions for Gabapentin, about half the volume of the typical Pennsylvania prescriber of this medication (97). Medicare paid an average of $36.62 per fill, versus $21.72 statewide.

How often this provider prescribes it

This provider
53
PA average
97.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$36.62
PA average
$21.72

Gross Part D cost per fill; not the patient's out-of-pocket price.

82
30-Day Fills
standardized to 30-day supplies
2,456
Days of Medication
total across all patients in 2023

About Hydrocortisone: Hydrocortisone is a man-made version of a natural substance (cortisol) made by the adrenal gland. Show more ▾

This drug is used to treat low cortisol levels caused by diseases of the adrenal gland (such as Addison's disease, adrenocortical insufficiency). Hydrocortisone belongs to a class of drugs known as corticosteroids. Corticosteroids are needed in many ways for the body to function well. They are important for salt and water balance and keeping blood pressure normal. The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.

In 2023, this provider wrote 49 Medicare prescriptions for Hydrocortisone, about 1.8 times the volume of the typical Pennsylvania prescriber of this medication (28). Medicare paid an average of $44.54 per fill, versus $22.79 statewide.

How often this provider prescribes it

This provider
49
PA average
28.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$44.54
PA average
$22.79

Gross Part D cost per fill; not the patient's out-of-pocket price.

76
30-Day Fills
standardized to 30-day supplies
2,163
Days of Medication
total across all patients in 2023

About Mounjaro: Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. It lowers blood sugar by causing the release of your body's natural insulin and decreasing the amount of sugar your liver makes. A glucose-dependent insulinotropic polypeptide (GIP) receptor and Glucose-like peptide-1 (GLP-1) receptor agonist to enhance glycemic control in adults with TYPE 2 DIABETES MELLITUS.

In 2023, this provider wrote 48 Medicare prescriptions for Mounjaro, about 2.8 times the volume of the typical Pennsylvania prescriber of this medication (17). Medicare paid an average of $1,392.84 per fill, versus $1,200.61 statewide.

How often this provider prescribes it

This provider
48
PA average
17.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,392.84
PA average
$1,200.61

Gross Part D cost per fill; not the patient's out-of-pocket price.

64.2
30-Day Fills
standardized to 30-day supplies
1,850
Days of Medication
total across all patients in 2023

About Humalog: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

In 2023, this provider wrote 48 Medicare prescriptions for Humalog, about 1.7 times the volume of the typical Pennsylvania prescriber of this medication (28). Medicare paid an average of $803.82 per fill, versus $631.50 statewide.

How often this provider prescribes it

This provider
48
PA average
28.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$803.82
PA average
$631.50

Gross Part D cost per fill; not the patient's out-of-pocket price.

73.9
30-Day Fills
standardized to 30-day supplies
2,175
Days of Medication
total across all patients in 2023

About Prolia: Denosumab is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. Show more ▾

Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases after menopause (in women), as you age, if someone in your family has osteoporosis, or if you take certain medications (such as prednisone) for long periods. This medication works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures). Denosumab belongs to a class of drugs called monoclonal antibodies. It prevents certain cells in the body (osteoclasts) from breaking down bone. A humanized monoclonal antibody and an inhibitor of the RANK LIGAND, which regulates OSTEOCLAST differentiation and bone remodeling. It is used as a BONE DENSITY CONSERVATION AGENT in the treatment of OSTEOPOROSIS.

In 2023, this provider wrote 48 Medicare prescriptions for Prolia, about 1.9 times the volume of the typical Pennsylvania prescriber of this medication (25). Medicare paid an average of $1,611.31 per fill, versus $1,491.25 statewide.

How often this provider prescribes it

This provider
48
PA average
25.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,611.31
PA average
$1,491.25

Gross Part D cost per fill; not the patient's out-of-pocket price.

228.2
30-Day Fills
standardized to 30-day supplies
6,730
Days of Medication
total across all patients in 2023

About Tresiba Flextouch U-200: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.

In 2023, this provider wrote 41 Medicare prescriptions for Tresiba Flextouch U-200, about 1.4 times the volume of the typical Pennsylvania prescriber of this medication (29). Medicare paid an average of $1,354.16 per fill, versus $1,171.65 statewide.

How often this provider prescribes it

This provider
41
PA average
29.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,354.16
PA average
$1,171.65

Gross Part D cost per fill; not the patient's out-of-pocket price.

114.5
30-Day Fills
standardized to 30-day supplies
3,421
Days of Medication
total across all patients in 2023

About Glipizide Er: Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.

In 2023, this provider wrote 38 Medicare prescriptions for Glipizide Er, about the same volume as the typical Pennsylvania prescriber of this medication (35). Medicare paid an average of $21.58 per fill, versus $21.26 statewide.

How often this provider prescribes it

This provider
38
PA average
35.0

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$21.58
PA average
$21.26

Gross Part D cost per fill; not the patient's out-of-pocket price.

94
30-Day Fills
standardized to 30-day supplies
2,810
Days of Medication
total across all patients in 2023

About Farxiga: Dapagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used in people with type 2 diabetes and heart disease to lower the risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sugar by your kidneys. Dapagliflozin is also used to treat kidney disease and heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sodium by your kidneys.

In 2023, this provider wrote 38 Medicare prescriptions for Farxiga, about 1.2 times the volume of the typical Pennsylvania prescriber of this medication (33). Medicare paid an average of $1,204.63 per fill, versus $886.40 statewide.

How often this provider prescribes it

This provider
38
PA average
33.0

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,204.63
PA average
$886.40

Gross Part D cost per fill; not the patient's out-of-pocket price.

80
30-Day Fills
standardized to 30-day supplies
2,400
Days of Medication
total across all patients in 2023

About Novolog Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.

In 2023, this provider wrote 34 Medicare prescriptions for Novolog Flexpen, about the same volume as the typical Pennsylvania prescriber of this medication (37). Medicare paid an average of $1,081.30 per fill, versus $898.23 statewide.

How often this provider prescribes it

This provider
34
PA average
37.0

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,081.30
PA average
$898.23

Gross Part D cost per fill; not the patient's out-of-pocket price.

65.6
30-Day Fills
standardized to 30-day supplies
1,932
Days of Medication
total across all patients in 2023

About Toujeo Max Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

In 2023, this provider wrote 33 Medicare prescriptions for Toujeo Max Solostar, about 1.4 times the volume of the typical Pennsylvania prescriber of this medication (24). Medicare paid an average of $1,468.00 per fill, versus $1,048.89 statewide.

How often this provider prescribes it

This provider
33
PA average
24.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,468.00
PA average
$1,048.89

Gross Part D cost per fill; not the patient's out-of-pocket price.

73.6
30-Day Fills
standardized to 30-day supplies
2,164
Days of Medication
total across all patients in 2023

About Atorvastatin Calcium: Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. Show more ▾

It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.

In 2023, this provider wrote 31 Medicare prescriptions for Atorvastatin Calcium, about 15% of the volume of the typical Pennsylvania prescriber of this medication (204). Medicare paid an average of $29.22 per fill, versus $14.17 statewide.

How often this provider prescribes it

This provider
31
PA average
204.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$29.22
PA average
$14.17

Gross Part D cost per fill; not the patient's out-of-pocket price.

89
30-Day Fills
standardized to 30-day supplies
2,670
Days of Medication
total across all patients in 2023

In 2023, this provider wrote 31 Medicare prescriptions for Omnipod 5 G6 Pods (Gen 5), about 1.8 times the volume of the typical Pennsylvania prescriber of this medication (17). Medicare paid an average of $1,019.46 per fill, versus $929.63 statewide.

How often this provider prescribes it

This provider
31
PA average
17.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,019.46
PA average
$929.63

Gross Part D cost per fill; not the patient's out-of-pocket price.

47
30-Day Fills
standardized to 30-day supplies
1,410
Days of Medication
total across all patients in 2023

About Unithroid: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾

It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

In 2023, this provider wrote 28 Medicare prescriptions for Unithroid, about 67% of the volume of the typical Pennsylvania prescriber of this medication (42). Medicare paid an average of $94.25 per fill, versus $26.12 statewide.

How often this provider prescribes it

This provider
28
PA average
42.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$94.25
PA average
$26.12

Gross Part D cost per fill; not the patient's out-of-pocket price.

82
30-Day Fills
standardized to 30-day supplies
2,460
Days of Medication
total across all patients in 2023

About Humulin R U-500 Kwikpen: Inhaled insulin powder is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a short-acting insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This product is absorbed into the blood through your lungs. It starts working faster and lasts for a shorter time than regular insulin injected under the skin. It is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin).

In 2023, this provider wrote 27 Medicare prescriptions for Humulin R U-500 Kwikpen, about the same volume as the typical Pennsylvania prescriber of this medication (26). Medicare paid an average of $1,336.12 per fill, versus $1,676.19 statewide.

How often this provider prescribes it

This provider
27
PA average
26.0

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,336.12
PA average
$1,676.19

This provider's average cost per fill is below the PA average for this medication.

30.4
30-Day Fills
standardized to 30-day supplies
834
Days of Medication
total across all patients in 2023

In 2023, this provider wrote 25 Medicare prescriptions for Ultra-Fine Mini Pen Needle, about 1.2 times the volume of the typical Pennsylvania prescriber of this medication (21). Medicare paid an average of $82.40 per fill, versus $81.63 statewide.

How often this provider prescribes it

This provider
25
PA average
21.0

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$82.40
PA average
$81.63

Gross Part D cost per fill; not the patient's out-of-pocket price.

73.3
30-Day Fills
standardized to 30-day supplies
2,200
Days of Medication
total across all patients in 2023

About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾

Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.

In 2023, this provider wrote 24 Medicare prescriptions for Prednisone, about half the volume of the typical Pennsylvania prescriber of this medication (48). Medicare paid an average of $15.48 per fill, versus $5.96 statewide.

How often this provider prescribes it

This provider
24
PA average
48.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$15.48
PA average
$5.96

Gross Part D cost per fill; not the patient's out-of-pocket price.

37.7
30-Day Fills
standardized to 30-day supplies
1,116
Days of Medication
total across all patients in 2023

About Basaglar Kwikpen U-100: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

In 2023, this provider wrote 24 Medicare prescriptions for Basaglar Kwikpen U-100, about 80% of the volume of the typical Pennsylvania prescriber of this medication (30). Medicare paid an average of $449.57 per fill, versus $382.38 statewide.

How often this provider prescribes it

This provider
24
PA average
30.0

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$449.57
PA average
$382.38

Gross Part D cost per fill; not the patient's out-of-pocket price.

48.8
30-Day Fills
standardized to 30-day supplies
1,444
Days of Medication
total across all patients in 2023

About Glipizide: Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.

In 2023, this provider wrote 22 Medicare prescriptions for Glipizide, about 63% of the volume of the typical Pennsylvania prescriber of this medication (35). Medicare paid an average of $31.01 per fill, versus $10.02 statewide.

How often this provider prescribes it

This provider
22
PA average
35.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$31.01
PA average
$10.02

Gross Part D cost per fill; not the patient's out-of-pocket price.

66
30-Day Fills
standardized to 30-day supplies
1,980
Days of Medication
total across all patients in 2023

About Insulin Aspart Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.

In 2023, this provider wrote 21 Medicare prescriptions for Insulin Aspart Flexpen, about the same volume as the typical Pennsylvania prescriber of this medication (20). Medicare paid an average of $752.26 per fill, versus $264.83 statewide.

How often this provider prescribes it

This provider
21
PA average
20.0

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$752.26
PA average
$264.83

Gross Part D cost per fill; not the patient's out-of-pocket price.

43.4
30-Day Fills
standardized to 30-day supplies
1,263
Days of Medication
total across all patients in 2023

In 2023, this provider wrote 20 Medicare prescriptions for Ultra-Fine Nano Pen Needle, about 87% of the volume of the typical Pennsylvania prescriber of this medication (23). Medicare paid an average of $69.14 per fill, versus $80.32 statewide.

How often this provider prescribes it

This provider
20
PA average
23.0

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$69.14
PA average
$80.32

This provider's average cost per fill is below the PA average for this medication.

45
30-Day Fills
standardized to 30-day supplies
1,305
Days of Medication
total across all patients in 2023

About Lyumjev Kwikpen U-100: Insulin lispro-aabc is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro-aabc is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro-aabc starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro-aabc may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

In 2023, this provider wrote 19 Medicare prescriptions for Lyumjev Kwikpen U-100, about 1.2 times the volume of the typical Pennsylvania prescriber of this medication (16). Medicare paid an average of $1,166.73 per fill, versus $833.74 statewide.

How often this provider prescribes it

This provider
19
PA average
16.0

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,166.73
PA average
$833.74

Gross Part D cost per fill; not the patient's out-of-pocket price.

27
30-Day Fills
standardized to 30-day supplies
795
Days of Medication
total across all patients in 2023

About Novolog: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.

In 2023, this provider wrote 19 Medicare prescriptions for Novolog, about 61% of the volume of the typical Pennsylvania prescriber of this medication (31). Medicare paid an average of $1,467.80 per fill, versus $825.27 statewide.

How often this provider prescribes it

This provider
19
PA average
31.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,467.80
PA average
$825.27

Gross Part D cost per fill; not the patient's out-of-pocket price.

39.4
30-Day Fills
standardized to 30-day supplies
1,177
Days of Medication
total across all patients in 2023

About Repaglinide: Repaglinide is used alone or with other medications to control high blood sugar along with a proper diet and exercise program. Show more ▾

It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. It works by stimulating the body to produce more insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet.

In 2023, this provider wrote 18 Medicare prescriptions for Repaglinide, about 60% of the volume of the typical Pennsylvania prescriber of this medication (30). Medicare paid an average of $45.04 per fill, versus $64.29 statewide.

How often this provider prescribes it

This provider
18
PA average
30.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$45.04
PA average
$64.29

This provider's average cost per fill is below the PA average for this medication.

38
30-Day Fills
standardized to 30-day supplies
1,140
Days of Medication
total across all patients in 2023

About Zoledronic Acid: This medication is used to treat high blood calcium levels (hypercalcemia) that may occur with cancer. Show more ▾

Zoledronic acid is also used with cancer chemotherapy to treat bone problems that may occur with multiple myeloma and other types of cancer (such as breast, lung) that have spread to the bones. Zoledronic acid belongs to a class of drugs known as bisphosphonates. It lowers high blood calcium levels by reducing the amount of calcium released from your bones into your blood. It also works by slowing the breakdown of your bones by cancer to prevent bone fractures. An imidobisphosphonate inhibitor of BONE RESORPTION that is used for the treatment of malignancy-related HYPERCALCEMIA; OSTEITIS DEFORMANS; and OSTEOPOROSIS.

In 2023, this provider wrote 18 Medicare prescriptions for Zoledronic Acid, about 1.6 times the volume of the typical Pennsylvania prescriber of this medication (11). Medicare paid an average of $276.29 per fill, versus $37.95 statewide.

How often this provider prescribes it

This provider
18
PA average
11.0

This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$276.29
PA average
$37.95

Gross Part D cost per fill; not the patient's out-of-pocket price.

75
30-Day Fills
standardized to 30-day supplies
2,017
Days of Medication
total across all patients in 2023

About Fenofibrate: Fenofibrate is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. Show more ▾

It works by increasing the natural substance (enzyme) that breaks down fats in the blood. Fenofibrate belongs to a group of drugs known as fibrates. Lowering triglycerides in people with very high triglyceride blood levels may decrease the risk of pancreas disease (pancreatitis). However, fenofibrate might not lower your risk of a heart attack or stroke. Talk to your doctor about the risks and benefits of fenofibrate. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. An antilipemic agent which reduces both CHOLESTEROL and TRIGLYCERIDES in the blood.

In 2023, this provider wrote 18 Medicare prescriptions for Fenofibrate, about 72% of the volume of the typical Pennsylvania prescriber of this medication (25). Medicare paid an average of $61.94 per fill, versus $47.24 statewide.

How often this provider prescribes it

This provider
18
PA average
25.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$61.94
PA average
$47.24

Gross Part D cost per fill; not the patient's out-of-pocket price.

28
30-Day Fills
standardized to 30-day supplies
840
Days of Medication
total across all patients in 2023

About Rybelsus: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment.

In 2023, this provider wrote 17 Medicare prescriptions for Rybelsus, about 74% of the volume of the typical Pennsylvania prescriber of this medication (23). Medicare paid an average of $1,115.57 per fill, versus $1,225.67 statewide.

How often this provider prescribes it

This provider
17
PA average
23.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,115.57
PA average
$1,225.67

This provider's average cost per fill is below the PA average for this medication.

21
30-Day Fills
standardized to 30-day supplies
630
Days of Medication
total across all patients in 2023

About Spironolactone: Spironolactone is used to treat high blood pressure and heart failure. Show more ▾

Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat swelling (edema) caused by certain conditions (such as heart failure, liver disease) by removing excess fluid and improving symptoms such as breathing problems. This medication is also used to treat conditions in which the body is making too much of a natural substance (aldosterone). Spironolactone is known as a water pill (potassium-sparing diuretic). A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)

In 2023, this provider wrote 17 Medicare prescriptions for Spironolactone, about a third of the volume of the typical Pennsylvania prescriber of this medication (41). Medicare paid an average of $22.17 per fill, versus $11.39 statewide.

How often this provider prescribes it

This provider
17
PA average
41.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$22.17
PA average
$11.39

Gross Part D cost per fill; not the patient's out-of-pocket price.

41
30-Day Fills
standardized to 30-day supplies
1,230
Days of Medication
total across all patients in 2023

About Januvia: Sitagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾

It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Sitagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES.

In 2023, this provider wrote 15 Medicare prescriptions for Januvia, about half the volume of the typical Pennsylvania prescriber of this medication (34). Medicare paid an average of $879.46 per fill, versus $897.35 statewide.

How often this provider prescribes it

This provider
15
PA average
34.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$879.46
PA average
$897.35

This provider's average cost per fill is below the PA average for this medication.

23
30-Day Fills
standardized to 30-day supplies
690
Days of Medication
total across all patients in 2023

About Tradjenta: Linagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾

It is used by people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Linagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS.

In 2023, this provider wrote 15 Medicare prescriptions for Tradjenta, about half the volume of the typical Pennsylvania prescriber of this medication (34). Medicare paid an average of $1,384.04 per fill, versus $688.41 statewide.

How often this provider prescribes it

This provider
15
PA average
34.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,384.04
PA average
$688.41

Gross Part D cost per fill; not the patient's out-of-pocket price.

41
30-Day Fills
standardized to 30-day supplies
1,230
Days of Medication
total across all patients in 2023

In 2023, this provider wrote 15 Medicare prescriptions for Sure Comfort Pen Needle, about 75% of the volume of the typical Pennsylvania prescriber of this medication (20). Medicare paid an average of $100.65 per fill, versus $67.98 statewide.

How often this provider prescribes it

This provider
15
PA average
20.0

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$100.65
PA average
$67.98

Gross Part D cost per fill; not the patient's out-of-pocket price.

43.3
30-Day Fills
standardized to 30-day supplies
1,300
Days of Medication
total across all patients in 2023

About Synjardy Xr: This medication is a combination of 2 drugs: empagliflozin and metformin. Show more ▾

It is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication works by helping to restore your body's proper response to the insulin you naturally produce. It also increases the removal of sugar by your kidneys, decreases how much sugar is made in your liver, and decreases how much sugar your body takes in through your stomach and intestines.

In 2023, this provider wrote 15 Medicare prescriptions for Synjardy Xr, about half the volume of the typical Pennsylvania prescriber of this medication (27). Medicare paid an average of $769.49 per fill, versus $917.03 statewide.

How often this provider prescribes it

This provider
15
PA average
27.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$769.49
PA average
$917.03

This provider's average cost per fill is below the PA average for this medication.

21
30-Day Fills
standardized to 30-day supplies
582
Days of Medication
total across all patients in 2023

In 2023, this provider wrote 14 Medicare prescriptions for Pen Needle, about the same volume as the typical Pennsylvania prescriber of this medication (15). Medicare paid an average of $19.85 per fill, versus $32.03 statewide.

How often this provider prescribes it

This provider
14
PA average
15.0

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$19.85
PA average
$32.03

This provider's average cost per fill is below the PA average for this medication.

16
30-Day Fills
standardized to 30-day supplies
415
Days of Medication
total across all patients in 2023

About Testosterone Cypionate: This medication is used in men who do not make enough of a natural substance called testosterone. Show more ▾

In males, testosterone is responsible for many normal functions, including growth and development of the genitals, muscles, and bones. It also helps cause normal sexual development (puberty) in boys. Testosterone belongs to a class of drugs known as androgens. It works by affecting many body systems so that the body can develop and function normally. Testosterone may also be used in certain adolescent boys to cause puberty in those with delayed puberty. It may also be used to treat certain types of breast cancer in women.

In 2023, this provider wrote 14 Medicare prescriptions for Testosterone Cypionate, about 67% of the volume of the typical Pennsylvania prescriber of this medication (21). Medicare paid an average of $65.03 per fill, versus $43.82 statewide.

How often this provider prescribes it

This provider
14
PA average
21.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$65.03
PA average
$43.82

Gross Part D cost per fill; not the patient's out-of-pocket price.

15.3
30-Day Fills
standardized to 30-day supplies
420
Days of Medication
total across all patients in 2023

About Humulin R U-500: Inhaled insulin powder is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a short-acting insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This product is absorbed into the blood through your lungs. It starts working faster and lasts for a shorter time than regular insulin injected under the skin. It is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin).

In 2023, this provider wrote 14 Medicare prescriptions for Humulin R U-500, about 78% of the volume of the typical Pennsylvania prescriber of this medication (18). Medicare paid an average of $2,006.16 per fill, versus $2,123.08 statewide.

How often this provider prescribes it

This provider
14
PA average
18.0

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$2,006.16
PA average
$2,123.08

This provider's average cost per fill is below the PA average for this medication.

19
30-Day Fills
standardized to 30-day supplies
570
Days of Medication
total across all patients in 2023

About Depo-Testosterone: This medication is used in men who do not make enough of a natural substance called testosterone. Show more ▾

In males, testosterone is responsible for many normal functions, including growth and development of the genitals, muscles, and bones. It also helps cause normal sexual development (puberty) in boys. Testosterone belongs to a class of drugs known as androgens. It works by affecting many body systems so that the body can develop and function normally. Testosterone may also be used in certain adolescent boys to cause puberty in those with delayed puberty. It may also be used to treat certain types of breast cancer in women.

In 2023, this provider wrote 14 Medicare prescriptions for Depo-Testosterone. Medicare paid an average of $22.52 per fill. No state comparison is available for this medication.

How often this provider prescribes it

No state benchmark is available for this medication.

What Medicare paid per fill

$22.52
Cost per fill

Gross Part D cost per fill; not the patient's out-of-pocket price.

14
30-Day Fills
standardized to 30-day supplies
308
Days of Medication
total across all patients in 2023

In 2023, this provider wrote 14 Medicare prescriptions for Droplet Pen Needle, about 74% of the volume of the typical Pennsylvania prescriber of this medication (19). Medicare paid an average of $98.00 per fill, versus $68.76 statewide.

How often this provider prescribes it

This provider
14
PA average
19.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$98.00
PA average
$68.76

Gross Part D cost per fill; not the patient's out-of-pocket price.

37.3
30-Day Fills
standardized to 30-day supplies
1,115
Days of Medication
total across all patients in 2023

About Humalog Kwikpen U-200: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

In 2023, this provider wrote 14 Medicare prescriptions for Humalog Kwikpen U-200, about 88% of the volume of the typical Pennsylvania prescriber of this medication (16). Medicare paid an average of $775.13 per fill, versus $1,406.26 statewide.

How often this provider prescribes it

This provider
14
PA average
16.0

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$775.13
PA average
$1,406.26

This provider's average cost per fill is below the PA average for this medication.

14
30-Day Fills
standardized to 30-day supplies
240
Days of Medication
total across all patients in 2023

In 2023, this provider wrote 13 Medicare prescriptions for Easy Touch Pen Needle, about 81% of the volume of the typical Pennsylvania prescriber of this medication (16). Medicare paid an average of $52.46 per fill, versus $50.43 statewide.

How often this provider prescribes it

This provider
13
PA average
16.0

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$52.46
PA average
$50.43

Gross Part D cost per fill; not the patient's out-of-pocket price.

13
30-Day Fills
standardized to 30-day supplies
317
Days of Medication
total across all patients in 2023

About Euthyrox: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾

It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

In 2023, this provider wrote 13 Medicare prescriptions for Euthyrox, about 65% of the volume of the typical Pennsylvania prescriber of this medication (20). Medicare paid an average of $8.54 per fill, versus $5.35 statewide.

How often this provider prescribes it

This provider
13
PA average
20.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$8.54
PA average
$5.35

Gross Part D cost per fill; not the patient's out-of-pocket price.

13
30-Day Fills
standardized to 30-day supplies
390
Days of Medication
total across all patients in 2023

About Pregabalin: This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. Show more ▾

This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures). A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA.

In 2023, this provider wrote 13 Medicare prescriptions for Pregabalin, about a third of the volume of the typical Pennsylvania prescriber of this medication (37). Medicare paid an average of $25.61 per fill, versus $52.12 statewide.

How often this provider prescribes it

This provider
13
PA average
37.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$25.61
PA average
$52.12

This provider's average cost per fill is below the PA average for this medication.

15
30-Day Fills
standardized to 30-day supplies
450
Days of Medication
total across all patients in 2023

About Desmopressin Acetate: Desmopressin is used to control the amount of urine your kidneys make. Show more ▾

Normally, the amount of urine you make is controlled by a certain substance in the body called vasopressin. In people who have water diabetes (diabetes insipidus) or certain kinds of head injury or brain surgery, the body does not make enough vasopressin. Desmopressin is a man-made form of vasopressin and is used to replace a low level of vasopressin. This medication helps to control increased thirst and too much urination due to these conditions, and helps prevent dehydration. Desmopressin is also used to control bleeding caused by surgery or injuries in people with certain bleeding problems (hemophilia A, type 1 von Willebrand's disease). It works by helping the body with normal blood clotting. A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR.

In 2023, this provider wrote 12 Medicare prescriptions for Desmopressin Acetate, about 63% of the volume of the typical Pennsylvania prescriber of this medication (19). Medicare paid an average of $148.69 per fill, versus $87.14 statewide.

How often this provider prescribes it

This provider
12
PA average
19.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$148.69
PA average
$87.14

Gross Part D cost per fill; not the patient's out-of-pocket price.

12
30-Day Fills
standardized to 30-day supplies
360
Days of Medication
total across all patients in 2023

About Omeprazole: Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). Show more ▾

It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). If you are self-treating with this medication, over-the-counter omeprazole products are used to treat frequent heartburn (occurring 2 or more days a week). Since it may take 1 to 4 days to have full effect, these products do not relieve heartburn right away. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar brand names may contain different ingredients meant for different purposes. Taking the wrong product could harm you. A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

In 2023, this provider wrote 12 Medicare prescriptions for Omeprazole, about 11% of the volume of the typical Pennsylvania prescriber of this medication (109). Medicare paid an average of $0.37 per fill, versus $14.36 statewide.

How often this provider prescribes it

This provider
12
PA average
109.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$0.37
PA average
$14.36

This provider's average cost per fill is below the PA average for this medication.

12
30-Day Fills
standardized to 30-day supplies
360
Days of Medication
total across all patients in 2023

About Raloxifene Hcl: Raloxifene is used by women to prevent and treat bone loss (osteoporosis) after menopause. Show more ▾

It slows down bone loss and helps to keep bones strong, making them less likely to break. Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive breast cancer) after menopause. Raloxifene is not an estrogen hormone, but it acts like estrogen in some parts of the body, like your bones. In other parts of the body (uterus and breasts), raloxifene acts like an estrogen blocker. It does not relieve menopause symptoms such as hot flashes. Raloxifene belongs to a class of drugs known as selective estrogen receptor modulators-SERMs. This medication should not be used before menopause. It should not be used to prevent heart disease. A second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.

In 2023, this provider wrote 12 Medicare prescriptions for Raloxifene Hcl, about half the volume of the typical Pennsylvania prescriber of this medication (21). Medicare paid an average of $66.34 per fill, versus $85.53 statewide.

How often this provider prescribes it

This provider
12
PA average
21.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$66.34
PA average
$85.53

This provider's average cost per fill is below the PA average for this medication.

32
30-Day Fills
standardized to 30-day supplies
960
Days of Medication
total across all patients in 2023

About Pioglitazone Hcl: Pioglitazone is a diabetes drug (thiazolidinedione-type, also called glitazones) used along with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes. Show more ▾

It works by helping to restore your body's proper response to insulin, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Pioglitazone is used either alone or in combination with other diabetes medications (such as metformin or a sulfonylurea such as glyburide). Talk to your doctor about the risks and benefits of pioglitazone.

In 2023, this provider wrote 12 Medicare prescriptions for Pioglitazone Hcl, about a third of the volume of the typical Pennsylvania prescriber of this medication (33). Medicare paid an average of $7.08 per fill, versus $21.21 statewide.

How often this provider prescribes it

This provider
12
PA average
33.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$7.08
PA average
$21.21

This provider's average cost per fill is below the PA average for this medication.

36
30-Day Fills
standardized to 30-day supplies
1,080
Days of Medication
total across all patients in 2023

About Lisinopril: Lisinopril is used to treat high blood pressure. Show more ▾

Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat heart failure and to improve survival after a heart attack. Lisinopril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily. One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure.

In 2023, this provider wrote 11 Medicare prescriptions for Lisinopril, about 8% of the volume of the typical Pennsylvania prescriber of this medication (135). Medicare paid an average of $9.18 per fill, versus $8.19 statewide.

How often this provider prescribes it

This provider
11
PA average
135.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$9.18
PA average
$8.19

Gross Part D cost per fill; not the patient's out-of-pocket price.

29
30-Day Fills
standardized to 30-day supplies
870
Days of Medication
total across all patients in 2023

About Insulin Lispro Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

In 2023, this provider wrote 11 Medicare prescriptions for Insulin Lispro Kwikpen U-100, about a third of the volume of the typical Pennsylvania prescriber of this medication (28). Medicare paid an average of $334.13 per fill, versus $161.43 statewide.

How often this provider prescribes it

This provider
11
PA average
28.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$334.13
PA average
$161.43

Gross Part D cost per fill; not the patient's out-of-pocket price.

20.6
30-Day Fills
standardized to 30-day supplies
611
Days of Medication
total across all patients in 2023

About Humalog Mix 75-25 Kwikpen: Insulin lispro protamine/insulin lispro is used along with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾

This product is a combination of two man-made insulins: intermediate-acting insulin lispro protamine and rapid-acting insulin lispro. This combination starts working faster and lasts for a longer time than regular insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. It replaces the insulin that your body no longer produces, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.

In 2023, this provider wrote 11 Medicare prescriptions for Humalog Mix 75-25 Kwikpen, about half the volume of the typical Pennsylvania prescriber of this medication (21). Medicare paid an average of $1,155.11 per fill, versus $1,070.92 statewide.

How often this provider prescribes it

This provider
11
PA average
21.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,155.11
PA average
$1,070.92

Gross Part D cost per fill; not the patient's out-of-pocket price.

14
30-Day Fills
standardized to 30-day supplies
420
Days of Medication
total across all patients in 2023
No medications match the current filters.
= the 5 medications this provider prescribes most. More than typical Typical Less than typical= prescription volume vs the average PA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the PA average cost per fill.

About this data. The prescription history for DR. LUCAS HELLER M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Endocrinology, Diabetes & Metabolism prescribing approach at this Irwin, PA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among PA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.